The ACET chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ACET chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ACET stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ACET Detailed Price Forecast - CNN Money||View ACET Detailed Summary - Google Finance|
|View ACET Detailed Summary - Yahoo! Finance||View ACET Stock Research & Analysis - Zacks.com|
|View ACET Trends & Analysis - Trade-Ideas||View ACET Major Holders - Barrons|
|View ACET Call Transcripts - NASDAQ||View ACET Breaking News & Analysis - Seeking Alpha|
|View ACET Annual Report - CompanySpotlight.com||View ACET OTC Short Report - OTCShortReport.com|
|View ACET Fundamentals - TradeKing||View ACET SEC Filings - Bar Chart|
|View Historical Prices for ACET - The WSJ||View Performance/Total Return for ACET - Morningstar|
|View the Analyst Estimates for ACET - MarketWatch||View the Earnings History for ACET - CNBC|
|View the ACET Earnings - StockMarketWatch||View ACET Buy or Sell Recommendations - MacroAxis|
|View the ACET Bullish Patterns - American Bulls||View ACET Short Pain Metrics - ShortPainBot.com|
|View ACET Stock Mentions - StockTwits||View ACET Stock Mentions - PennyStockTweets|
|View ACET Stock Mentions - Twitter||View ACET Investment Forum News - Investor Hub|
|View ACET Stock Mentions - Yahoo! Message Board||View ACET Stock Mentions - Seeking Alpha|
|View Insider Transactions for ACET - SECform4.com||View Insider Transactions for ACET - Insider Cow|
|View ACET Major Holdings Summary - CNBC||View Insider Disclosure for ACET - OTC Markets|
|View Insider Transactions for ACET - Yahoo! Finance||View Institutional Holdings for ACET - NASDAQ|
|View ACET Stock Insight & Charts - FinViz.com||View ACET Investment Charts - StockCharts.com|
|View ACET Stock Overview & Charts - BarChart||View ACET User Generated Charts - Trading View|
ACETO Completes the Sale of Its Chemicals Business Assets
Posted on Tuesday April 30, 2019
ACETO Corporation (ACETQ) announced today that it has completed the previously disclosed sale of its chemicals business assets to an affiliate of New Mountain Capital, a leading growth-oriented investment firm with over $20 billion in assets under management.
ACETO Completes the Sale of Rising Pharmaceuticals
Posted on Monday April 22, 2019
PORT WASHINGTON, N.Y., April 22, 2019 -- ACETO Corporation (Nasdaq: ACETQ), an international company engaged in the development, marketing, sale and distribution of Human.
ACETO to Sell its Chemicals Business Assets to New Mountain Capital
Posted on Monday April 15, 2019
ACETO Corporation (ACETQ), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that it has agreed to sell its chemicals business assets to an affiliate of New Mountain Capital (“NMC”), a leading growth-oriented investment firm with over $20 billion in assets under management. The asset purchase agreement was entered into following the conclusion of a court-supervised sale process conducted under Section 363 of the U.S. Bankruptcy Code. Under that process, an asset purchase agreement between Aceto and NMC was executed, dated February 18, 2019, to sell the chemical business assets as the “stalking horse agreement”.
ACETO Receives Court Approval of “Stalking Horse” Agreement to Sell Rising Pharmaceuticals to Shore Suven Pharma, Inc.
Posted on Friday April 12, 2019
ACETO Corporation (ACETQ), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today that it has received approval from the U.S. Bankruptcy Court to sell the assets of Rising Pharmaceuticals and Rising’s subsidiaries to Shore Suven Pharma, Inc. for gross cash proceeds of $15 million, plus the assumption of operating liabilities and customer obligations related to the acquired business, on a cash-free and debt-free basis. The sale was conducted through a Court-supervised process under Section 363 of the Bankruptcy Code. Under that process, Shore Suven Pharma’s purchase agreement served as the “stalking horse agreement” and an auction would have been conducted had the Company received qualified offers from other bidders reflecting potentially higher and/or otherwise better terms.